Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:56 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 433–456 of 612 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: iron Clear all

Conditions: Iron Deficiency, Anaemia in Children
Interventions: Ferric Derisomaltose; Drug
Lead sponsor: Pharmacosmos A/S; Industry
Eligibility: Up to 17 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Erythropoietic Protoporphyria, EPP, X-linked Protoporphyria, XLP
Interventions: Oral Iron; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 6
States / cities: Birmingham, Alabama • San Francisco, California • New York, New York + 3 more

Conditions: Obstructive Sleep Apnea
Interventions: Negative Pressure Ventilator, Pulmonary Function Testing (PFT), Transcutaneous Phrenic Nerve Stimulation, Percutaneous Phrenic Nerve Stimulation; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Beta-thalassemia, Myelodysplastic Syndromes, Fanconi Syndrome, Anemia, Diamond-Blackfan, Anemia, Aplastic
Interventions: Deferasirox; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 2 Years and older
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 6
States / cities: Oakland, California • Stanford, California • Arlington Heights, Illinois + 3 more

Conditions: Pregnancy Anemia, Newborn; Anemia
Interventions: Not listed
Lead sponsor: Cornell University; Other
Eligibility: 11 Years to 45 Years · Female only
Enrollment: 338 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2017
U.S. locations: 2
States / cities: Rochester, New York

Conditions: Colorectal Cancer
Interventions: Ferumoxytol, Magnetic Resonance Imaging; Drug · Other
Lead sponsor: Scott Potenta, MD, PhD; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Iron Deficiency Anemia, Iron-deficiency
Interventions: 95% condensed proanthocyanidins from grape seed extract; Dietary Supplement
Lead sponsor: Kansas State University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Manhattan, Kansas

Conditions: Sickle Cell Disease
Interventions: Alemtuzumab, Fludarabine, Melphalan, Stem Cells; Drug · Procedure
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 2 Years to 30 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2021
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Depressive Symptoms
Interventions: Brief Interpersonal Psychotherapy - Adolescent Skills Training (B-IPT-AST), Services as usual (SAU); Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 13 Years to 17 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Colon Inflammation, Iron Malabsorption, Obesity, Diet Modification
Interventions: High heme iron diet, Low iron diet, Plant-based high non-heme iron diet; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 55 Years to 70 Years · Female only
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Micronutrient Deficiencies
Interventions: MNP + Zn/Fe, MNP + Zn, Placebo; Dietary Supplement
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 5 Months to 10 Months
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Anemia
Interventions: Epoetin Alfa plus Iron; Drug
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Depression
Interventions: Placebos, Ketamine, Nitroprusside; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 21 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Anemia
Interventions: Ferric Carboxymaltose (FCM), Ferrous Sulfate tablets; Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 456 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Norristown, Pennsylvania

Conditions: End Stage Renal Disease, Chronic Kidney Disease
Interventions: SFP, Placebo; Drug · Other
Lead sponsor: Rockwell Medical Technologies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 718 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 28
States / cities: Mobile, Alabama • Northridge, California • Arvada, Colorado + 24 more

Conditions: Iron Deficiency
Interventions: Ferrous gluconate- 19 mg, Ferrous gluconate- 38 mg, Letter Group- Information Provided, Letter - No Information Provided, Placebo; Dietary Supplement · Other
Lead sponsor: Westat; Other
Eligibility: 18 Years to 100 Years
Enrollment: 702 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 4
States / cities: Farmington, Connecticut • Rockville, Maryland • Pittsburgh, Pennsylvania + 1 more

Conditions: Anemia
Interventions: Ferrous Sulfate tablets, Ferric Carboxymaltose (FCM); Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 255 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Norristown, Pennsylvania

Conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia
Interventions: Iron isomaltoside/ferric derisomaltose, Ferric carboxymaltose; Drug
Lead sponsor: Pharmacosmos A/S; Industry
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 15
States / cities: Muscle Shoals, Alabama • Doral, Florida • Miami, Florida + 11 more

Conditions: Hemorrhage, Anemia
Interventions: Ferrous sulfate, Capsule Endoscopy; Dietary Supplement · Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Myelofibrosis, Myelofibrosis; Anemia
Interventions: Nelfinavir; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Orange, California

Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Preserved Ejection Fraction (HFPEF), Iron Deficiency, Iron-deficiency Anemia (IDA)
Interventions: Ferric Carboxymaltose, Ferrous Sulfate; Drug
Lead sponsor: Syed Hamza Mufarrih; Other
Eligibility: 18 Years to 100 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Bowling Green, Kentucky

Conditions: Transfusional Iron Overload, Beta-thalassemia
Interventions: SPD602 (FBS0701, SSP-004184); Drug
Lead sponsor: Shire; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Oakland, California • Boston, Massachusetts

Conditions: Iron Deficiency Anemia, Malaria
Interventions: Iron Supplement; Dietary Supplement
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 70 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Iron Deficiency
Interventions: Fer-In-Sol (ferrous sulfate), Iron fortified cereal; Dietary Supplement
Lead sponsor: National Institutes of Health (NIH); NIH
Eligibility: 1 Month to 24 Months
Enrollment: 171 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: Iowa City, Iowa

Search by objective public record fields.

Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia

Oral Iron for Erythropoietic Protoporphyrias

Effects of Lung Volume on Upper Airway Patency During Drug Induced Sleep Endoscopy

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias

Erythroferrone and Its Impact on Maternal and Neonatal Iron Homeostasis

Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer

Multiple Daily Condensed Tannin Supplementation and Iron Bioavailability: The Tannin Dose Response Trial

Stem Cell Transplantation for Sickle Cell Anemia

Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)

Obesity, Iron Regulation and Colorectal Cancer Risk

Effect of Sprinkles With and w/o Fe on Zn Absorption in Kenyan Toddlers

Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia

Ketamine and Nitroprusside for Depression

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding

Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis

Strategies to Reduce Iron Deficiency

VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding

Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow

IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches

Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload

Impact of Host Iron Status and Iron Supplement Use on Erythrocytic Stage of Plasmodium Falciparum

Iron and the Breast-Fed Infant: Iron Status and Two Regimens of Iron Supplementation